HCW Biologics Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HCW Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q4 2024.
  • HCW Biologics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.16M, a 70.7% increase year-over-year.
  • HCW Biologics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$29.5M, a 14.6% decline year-over-year.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2024 was -$29.5M, a 14.6% decline from 2023.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2023 was -$25.7M, a 70.6% decline from 2022.
  • HCW Biologics Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 12.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$29.5M -$3.16M +$7.61M +70.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$37.1M -$3.69M +$1.39M +27.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$38.5M -$15.1M -$10.6M -236% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$27.9M -$7.49M -$2.13M -39.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$25.7M -$10.8M -$5.1M -90% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$20.6M -$5.08M -$1.06M -26.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$19.6M -$4.51M -$999K -28.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$18.6M -$5.36M -$3.48M -185% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$15.1M -$5.67M -$2.55M -82.1% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-15
Q3 2022 -$12.5M -$4.02M +$72.5K +1.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$12.6M -$3.51M -$760K -27.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$11.8M -$1.88M +$1.53M +44.9% Jan 1, 2022 Mar 31, 2022 10-Q/A 2023-08-10
Q4 2021 -$13.4M -$3.11M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$4.09M -$1.38M -51.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$2.75M +$29K +1.04% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$3.41M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$2.71M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$2.78M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.